Should You Buy Tenet Healthcare Corporation Stock in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Tenet Healthcare Corporation (THC) is rated as a strong fundamental performer with a QOC score of 8.3/10. Trading at $260.85, our valuation engine evaluates whether the market price reflects the company's underlying earnings power.
The short answer: 6 of 11 CirclFi valuation models project upside for Tenet Healthcare Corporation (THC) at $260.85 — the model consensus leans bullish, with a Quality Score of 8.3/10 and Value-Trap risk of 5/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.
What Is the Investment Case for Tenet Healthcare Corporation (THC) in 2026?
What Is the Bull Case vs the Bear Case for Tenet Healthcare Corporation (THC)?
| Bull case — $518.36 target (+98.7%) | Bear case — $94.85 target (-63.6%) |
|---|---|
| According to the CirclFi Quality of Company (QOC) framework, Tenet Healthcare Corporation's score of 8.3/10 reflects durable competitive advantages that should sustain earnings power through market cycles. | According to the CirclFi Deep Alpha Valuation Engine, the EROIC Spread model sees the stock as overvalued with a fair value of $94.85 (-63.6%), suggesting that the market price embeds overly optimistic growth assumptions. |
| According to the CirclFi Deep Alpha Valuation Engine, the Markov DDM model targets a fair value of $518.36 (+98.7%), anchoring the bull case with a methodology that provides a differentiated analytical lens. | According to the CirclFi Deep Alpha Valuation Engine, model disagreement is high with a +162.4% spread between the most bullish and bearish models, signaling elevated analytical uncertainty. |
How Does THC Compare to Its Medical Care Facilities Peers?
Valuation data pages: NUTX · PNTG · OPCH · CHE · ENSG · ARDT · LFST · SYRA · CMPS · ADUS · NHC
Which Other Stocks Score Like THC on Quality?
Closest companies to THC’s Quality of Company score of 8.3/10, across all industries.
- LOB — Live Oak Bancshares, Inc. (QOC 8.3) · analysis
- TIMB — TIM S.A. (QOC 8.3) · analysis
- REX — REX American Resources Corporation (QOC 8.3) · analysis
- CIEN — Ciena Corporation (QOC 8.3) · analysis
- ERIC — Telefonaktiebolaget LM Ericsson (publ) (QOC 8.3) · analysis
- MALG — Microalliance Group Inc. (QOC 8.3) · analysis
- NVDA — NVIDIA Corporation (QOC 10.0) · analysis
Which Medical Care Facilities Screens Does THC Appear In?
So Is Tenet Healthcare Corporation (THC) Worth Buying in 2026?
Our models don't have a clear verdict on Tenet Healthcare Corporation. At $260.85 vs. $261.55 median fair value, the median upside of +0.3% masks significant model disagreement (+162.4% spread). With quality at 8.3/10, this is a stock where the margin of error is wide and additional fundamental research is strongly recommended.
These are quantitative model outputs, not investment recommendations. Tenet Healthcare Corporation's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →
What Else Do Investors Ask About THC Stock?
Should I buy THC stock right now?
Based on CirclFi's multi-model analysis, 6 of 11 models see upside for THC at $260.85. The majority of models suggest the stock trades below fair value, but investors should weigh this against the Quality Score of 8.3/10 and individual risk tolerance. This is not a buy recommendation — see our full disclaimer.
What are the biggest risks of investing in Tenet Healthcare Corporation?
Key risks include: wide model disagreement (446% spread), signaling high uncertainty; general market and sector-specific risks affecting Medical Care Facilities companies. Always diversify and consult a financial advisor.
How does THC compare to its competitors?
Among Medical Care Facilities peers, THC holds a Quality Score of 8.3/10. Comparable companies include NUTX (QOC 8.4), PNTG (QOC 8.3), OPCH (QOC 8.4). The relative ranking helps investors identify whether THC offers better fundamental quality than alternatives in the same sector.
Is THC a good long-term investment?
Long-term investment potential depends on fundamental quality and sustainable competitive advantages. THC's Quality Score of 8.3/10 is encouraging for long-term holders, indicating consistent profitability, manageable debt, and healthy cash flows. Check our full data page for all 13 model estimates.
What price should I buy THC at?
CirclFi does not provide target buy prices or price alerts. However, our 11 active models produce fair value estimates ranging from $94.85 to $518.36. At $260.85, the stock trades within the range of model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.
Want the complete picture?
See all 13 model estimates, confidence scores, and the full valuation table for THC.
Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →
Buy with Gumroad